|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: BELLSOUTH CORP, 10-Q, EX-27, 2000-11-07 |
Next: TUXIS CORP, 3, 2000-11-07 |
<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)
(Amendment No. 0)*
Immucor, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.10 par value
--------------------------------------------------------------------------------
(Title of Class of Securities)
452526106
--------------------------------------
(CUSIP Number)
James F. Rice, Managing Director Copy to: Kenneth Wolfe
c/o Aim High Enterprises, Inc. StoneGate Partners, LLC
600 Longwater Drive, Suite 204 45 Milk Street, 7/th/ Floor
Norwell, MA 02061 Boston, MA 02109
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
October 30, 2000
----------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following
box.[_].
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See (S) 240.13d-7(b) for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 12 pages
<PAGE>
----------------- SCHEDULE 13D
CUSIP NO. 452526106 13D
-----------------
------------------------------------------------------------------------------
NAMES OF REPORTING PERSONS
1 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).
Kairos Partners, LP
Tax ID: 04-3521249
------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
2 (a) [_]
(b) [X]
------------------------------------------------------------------------------
SEC USE ONLY
3
------------------------------------------------------------------------------
SOURCE OF FUNDS (See Instructions)
4
WC - See Item 3
------------------------------------------------------------------------------
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e) [_]
5
------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
Delaware
------------------------------------------------------------------------------
SOLE VOTING POWER
7
NUMBER OF
None
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 8
OWNED BY 426,100 - See Item 5
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
9
REPORTING
None
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 10
426,100 - See Item 5
------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11
426,100
------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
12
[_]
------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
5.9% (based on 7,277,617 shares of Common Stock outstanding as of October
3, 2000 as reported by the Issuer in its Form 10-Q for the quarter ended
August 31, 2000)
------------------------------------------------------------------------------
TYPE OF REPORTING PERSON
14
PN
------------------------------------------------------------------------------
Page 2 of 12 pages
<PAGE>
----------------- SCHEDULE 13D
CUSIP NO. 452526106 13D
-----------------
------------------------------------------------------------------------------
NAMES OF REPORTING PERSONS
1 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).
Kairos Partners GP, LLC
------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
2 (a) [_]
(b) [X]
------------------------------------------------------------------------------
SEC USE ONLY
3
------------------------------------------------------------------------------
SOURCE OF FUNDS
4
OO - See Item 3
------------------------------------------------------------------------------
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e) [_]
5
------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
Delaware
------------------------------------------------------------------------------
SOLE VOTING POWER
7
NUMBER OF
None
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 8
OWNED BY 426,100 - See Item 5
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
9
REPORTING
None
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 10
426,100 - See Item 5
------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11
426,100
------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
12
[_]
------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
5.9% (based on 7,277,617 shares of Common Stock outstanding as of October
3, 2000 as reported by the Issuer in its Form 10-Q for the quarter ended
August 31, 2000)
------------------------------------------------------------------------------
TYPE OF REPORTING PERSON
14
OO - limited liability corporation
------------------------------------------------------------------------------
Page 3 of 12 pages
<PAGE>
----------------- SCHEDULE 13D
CUSIP NO. 452526106 13D
-----------------
------------------------------------------------------------------------------
NAMES OF REPORTING PERSONS
1 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only).
Aim High Enterprises, Inc.
------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
2 (a) [_]
(b) [X]
------------------------------------------------------------------------------
SEC USE ONLY
3
------------------------------------------------------------------------------
SOURCE OF FUNDS (See Instructions)
4
OO - See Item 3
------------------------------------------------------------------------------
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e) [_]
5
------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
Delaware
------------------------------------------------------------------------------
SOLE VOTING POWER
7
NUMBER OF
None
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 8
OWNED BY 426,100 - See Item 5
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
9
REPORTING
None
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 10
426,100 - See Item 5
------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11
426,100
------------------------------------------------------------------------------
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
12
[_]
------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
5.9% (based on 7,277,617 shares of Common Stock outstanding as of October
3, 2000 as reported by the Issuer in its Form 10-Q for the quarter ended
August 31, 2000)
------------------------------------------------------------------------------
TYPE OF REPORTING PERSON (See Instructions)
14
CO
------------------------------------------------------------------------------
Page 4 of 12 pages
<PAGE>
----------------- SCHEDULE 13D
CUSIP NO. 452526106 13D
-----------------
------------------------------------------------------------------------------
NAMES OF REPORTING PERSONS
1 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).
StoneGate Partners, LLC
------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
2 (a) [_]
(b) [X]
------------------------------------------------------------------------------
SEC USE ONLY
3
------------------------------------------------------------------------------
SOURCE OF FUNDS
4
OO - See Item 3
------------------------------------------------------------------------------
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e) [_]
5
------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
Massachusetts
------------------------------------------------------------------------------
SOLE VOTING POWER
7
NUMBER OF
None
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 8
OWNED BY 426,100 - See Item 5
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
9
REPORTING
None
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 10
426,100 - See Item 5
------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11
426,100
------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
12
[_]
------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
13
5.9% (based on 7,277,617 shares of Common Stock outstanding as of October
3, 2000 as reported by the Issuer in its Form 10-Q for the quarter ended
August 31, 2000)
------------------------------------------------------------------------------
TYPE OF REPORTING PERSON
14
OO - limited liability corporation
------------------------------------------------------------------------------
Page 5 of 12 pages
<PAGE>
Item 1. Security and Issuer
-------------------
(a) This statement relates to the common stock, $.10 par value per share, of
Immucor, Inc. (the "Common Stock"), (CUSIP No. 452526106)
(b) The names and addresses of the principal executive officers of the Issuer
are as follows:
Edward L. Gallup, President and Chief Executive Officer
Ralph A. Eatz, Senior Vice President - Operations
Dr. Gioacchhino De Chirico, Director of European Operations and President
Immucor Italia S.r.1
Steven C. Ramsey, Vice President - Chief Financial Officer and Secretary
Patrick Waddy, President of Dominion Biologicals Limited and European
Finance Director
Address: c/o Immucor, Inc.
3130 Gateway Drive
P.O. Box 5625
Norcross, Georgia 30091
Item 2. Identity and Background
1. (a) Kairos Partners, LP, ("Kairos") a limited partnership organized under
the laws of the State of Delaware.
(b) Address: c/o Aim High Enterprises, Inc.
600 Longwater Drive, Suite 204
Norwell, MA 02061
(c) Principal Business: Investments
(d) During the last five years, Kairos has not been convicted in a
criminal proceeding.
(e) During the last five years, Kairos was not a party to a civil
proceeding of a judicial or administrative body of competent
jurisdiction and as a result of such proceeding was or is subject to a
judgment, decree or final order enjoining future violations of, or
prohibiting or mandating activities subject to, federal or state
securities laws or finding any violation with respect to such laws
2. (a) Kairos Partners GP, LLC, a limited liability corporation organized
under the laws of the State of Delaware ("Kairos GP"). Kairos GP is
the general partner of Kairos.
(b) Address: c/o Aim High Enterprises, Inc.
600 Longwater Drive, Suite 204
Norwell, MA 02061
(c) Principal Business: Investments
(d) During the last five years, Kairos GP has not been convicted in a
criminal proceeding.
(e) During the last five years, Kairos GP was not a party to a civil
proceeding of a judicial or administrative body of competent
jurisdiction and as a result of such proceeding was or is subject to a
judgment, decree or final order enjoining future violations of, or
prohibiting or mandating activities subject to, federal or state
securities laws or finding any violation with respect to such laws
3. (a) Aim High Enterprises, Inc. jointly controls Kairos GP with StoneGate
Partners, LLC
(b) Address: Aim High Enterprises, Inc.
600 Longwater Drive, Suite 204
Norwell, MA 02061
(c) Principal Business: Investments
(d) During the last five years, Aim High Enterprises, Inc. has not been
convicted in a criminal proceeding.
(e) During the last five years, Aim High Enterprises, Inc. was not a party
to a civil proceeding of a judicial or administrative body of
competent jurisdiction and as a result of such proceeding was or is
subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to,
federal or state securities laws or finding any violation with respect
to such laws.
(f) Aim High Enterprises, Inc. is a corporation organized under the laws
of the State of Delaware.
Page 6 of 12 pages
<PAGE>
4. (a) StoneGate Partners, LLC jointly controls Kairos GP with Aim High
Enterprises, Inc.
(b) Address: StoneGate Partners, LLC
45 Milk Street, 7/th/ Floor
Boston, MA 02109
(c) Principal Business: Investments
(d) During the last five years, StoneGate Partners, LLC has not been
convicted in a criminal proceeding.
(e) During the last five years, StoneGate Partners, LLC was not a party to
a civil proceeding of a judicial or administrative body of competent
jurisdiction and as a result of such proceeding was or is subject to a
judgment, decree or final order enjoining future violations of, or
prohibiting or mandating activities subject to, federal or state
securities laws or finding any violation with respect to such laws.
(f) Stonegate Partners, LLC is limited liability corporation organized
under the laws of the Commonwealth of Massachusetts.
Item 3. Source and Amount of Funds or Other Consideration
-------------------------------------------------
The amount of funds used in acquiring the Common Stock was $1,690,371. The
source of these funds was Kairos' current cash equivalent assets (working
capital).
Item 4. Purpose of Transaction
----------------------
The shares, the ownership of which is reported hereby, were acquired by
Kairos for investment purposes. Kairos reserves the right from time to time to
acquire additional shares, or to dispose of some or all of its shares.
Except as set forth above, Kairos does not currently have any plans or
proposals which relate to, or would result in, any of the matters referred to in
paragraphs (a) through (j) of Item 4 of Schedule 13D, although in the future it
may develop such plans or proposals.
Item 5. Interest in Securities of the Issuer
------------------------------------
(a) The following list sets forth the aggregate number and percentage (based on
7,277,617 shares of Common Stock outstanding as of October 3, 2000 as
reported by the Issuer in its Form 10-Q for the quarter ended August 31,
2000) of outstanding shares of Common Stock owned beneficially by each
reporting person named in Item 2, as of November 7, 2000:
<TABLE>
<CAPTION>
Shares of Common Stock Percentage of Shares of Common Stock
Name Beneficially Owned Beneficially Owned
---- ------------------ ------------------
<S> <C> <C>
Kairos Partners, LP 426,100 5.9%
Kairos Partners GP, LLC (1) 426,100 5.9
Aim High Enterprises, Inc. (1) 426,100 5.9
StoneGate Partners, LLC (1) 426,100 5.9
</TABLE>
(1) The reporting person disclaims beneficial ownership of these securities
except to the extent of his/its equity interest therein.
(b) Kairos has sole power to vote and to dispose of 426,100 shares of Common
Stock, representing 5.9% of the outstanding Common Stock.
Kairos GP, by virtue of being the general partner of Kairos, may be deemed
to have shared power to vote and to dispose of 426,100 shares of Common
Stock, representing 5.9% of the outstanding Common Stock.
Aim High Enterprises, Inc., by virtue of being a joint controller of Kairos
GP with StoneGate Partners, LLC, may be deemed to have shared power to vote
and to dispose of 426,100 shares of Common Stock, representing 5.9% of the
outstanding Common Stock.
StoneGate Partners, LLC, by virtue of being a joint controller of Kairos GP
with Aim High Enterprises, Inc.,
Page 7 of 12 pages
<PAGE>
may be deemed to have shared power to vote and to dispose of 426,100 shares
of Common Stock, representing 5.9% of the outstanding Common Stock.
(c) The following is a description of all transaction in shares of Common Stock
of the Issuer by the reporting person identified in Item 2 of this Schedule
13D effected from September 8 to November 7, 2000:
See Appendix A.
(d) Not applicable
(e) Not applicable
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
---------------------------------------------------------------------
to Securities of the Issuer
---------------------------
Not applicable.
Item 7. Material to be Filed as Exhibits
--------------------------------
Not applicable.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
November 7, 2000
-----------------------------
(Date)
/s/ James F. Rice
-----------------------------
(Signature)
-----------------------------
James F. Rice, Managing Director
Page 8 of 12 pages
<PAGE>
Appendix A
<TABLE>
<CAPTION>
Date of Number of Shares Purchase or Sale
Name of Purchase of Purchased or Price per
Shareholder Sale (Sold) Share
-------------------------- ------------------ ---------------------- -------------------
<S> <C> <C> <C>
Kairos 11/06/2000 3,500 $ 4 11/20
1,000 $ 4 6/11
1,000 $ 4 6/11
1,000 $ 4 6/11
1,000 $ 4 17/33
900 $ 4 34/53
800 $ 4 49/80
800 $ 4 43/74
800 $ 4 43/74
800 $ 4 43/74
800 $ 4 43/74
800 $ 4 43/74
800 $ 4 43/74
700 $ 4 7/12
500 $ 4 19/29
500 $ 4 58/93
500 $ 4 58/93
500 $ 4 58/93
500 $ 4 58/93
500 $ 4 58/93
500 $ 4 58/93
500 $ 4 58/93
500 $ 4 1/2
500 $ 4 1/2
500 $ 4 1/2
500 $ 4 15/32
200 $ 4 9/16
100 $ 4 9/16
Kairos 11/02/2000 4,800 $ 4 47/73
1,200 $ 4 25/39
200 $ 4 50/87
Kairos 11/01/2000 1,500 $ 4 11/19
1,100 $ 4 41/75
1,000 $ 4 49/73
1,000 $ 4 49/73
1,000 $ 4 6/11
500 $ 4 35/51
500 $ 4 35/51
500 $ 4 35/51
500 $ 4 35/51
500 $ 4 35/51
500 $ 4 58/93
500 $ 4 58/93
500 $ 4 55/98
400 $ 4 43/62
200 $ 4 19/26
200 $ 4 20/33
Kairos 10/31/2000 100 $ 4 63/97
Kairos 10/30/2000 3,000 $ 4 67/75
3,000 $ 4 14/27
1,500 $ 4 74/83
1,500 $ 4 74/83
1,500 $ 4 37/43
1,500 $ 4 69/98
1,500 $ 4 11/19
1,500 $ 4 31/60
1,500 $ 4 33/68
1,300 $ 4 29/35
1,100 $ 4 26/37
1,000 $ 4 60/61
1,000 $ 4 11/15
1,000 $ 4 11/15
700 $ 4 25/51
500 $ 5
500 $ 5
500 $ 5
500 $ 4 16/19
500 $ 4 3/4
500 $ 4 3/4
300 $ 4 27/40
100 $ 4 77/92
100 $ 4 42/59
Kairos 10/26/2000 700 $ 4 19/91
2,700 $ 4 11/41
1,500 $ 4 14/47
1,000 $ 4 6/35
</TABLE>
Page 9 of 12 pages
<PAGE>
<TABLE>
<CAPTION>
Date of Number of Shares Purchase or Sale
Name of Purchase of Purchased or Price per
Shareholder Sale (Sold) Share
-------------------------- ------------------ ---------------------- -------------------
<S> <C> <C> <C>
Kairos 10/26/2000 1,000 $ 4 6/35
3,000 $ 4 7/34
500 $ 4 17/42
1,500 $ 4 9/23
300 $ 4 14/59
1,500 $ 4 14/47
3,000 $ 4 3/10
4,000 $ 4 1/3
Kairos 10/25/2000 1,000 $ 4 1/13
1,700 $ 4 7/88
1,600 $ 4 1/7
3,000 $ 4 8/99
1,000 $ 4 1/13
2,000 $ 4 2/25
2,500 $ 4 7/87
2,500 $ 4 7/87
1,000 $ 4 9/34
500 $ 4 7/25
100 $ 4 2/5
500 $ 4 5/23
1,000 $ 4 17/84
1,000 $ 4 9/34
Kairos 10/24/2000 100 $ 4 8/97
4,800 $ 4 7/86
1,500 $ 4 1/60
1,500 $ 4 1/60
2,500 $ 4 2/39
2,000 $ 3 72/73
2,000 $ 3 85/89
200 $ 4 1/82
Kairos 10/23/2000 1,000 $ 3 19/42
100 $ 3 63/97
1,500 $ 3 69/98
1,500 $ 3 69/98
Kairos 10/20/2000 1,000 $ 3 15/31
1,000 $ 3 15/31
2,000 $ 3 32/97
1,000 $ 3 19/58
1,000 $ 3 15/31
1,000 $ 3 15/31
1,000 $ 3 19/42
1,000 $ 3 15/31
</TABLE>
Page 10 of 12 pages
<PAGE>
<TABLE>
<CAPTION>
Date of Number of Shares Purchase or Sale
Name of Purchase of Purchased or Price per
Shareholder Sale (Sold) Share
-------------------------- ------------------ ---------------------- -------------------
<S> <C> <C> <C>
Kairos 10/19/2000 500 $ 3 16/27
3,000 $ 3 14/27
100 $ 3 63/97
2,000 $ 3 15/53
4,000 $ 3 14/27
1,000 $ 3 41/71
Kairos 10/18/2000 2,000 $ 3 31/79
1,500 $ 3 31/60
1,100 $ 3 50/97
500 $ 3 5/23
3,000 $ 3 11/41
3,400 $ 3 3/10
Kairos 10/17/2000 1,000 $ 3 6/11
1,000 $ 3 6/11
500 $ 3 55/98
Kairos 10/16/2000 2,200 $ 3 44/85
200 $ 3 50/87
1,200 $ 3 25/39
Kairos 10/11/2000 2,000 $ 3 8/39
1,500 $ 3 4/15
2,500 $ 3 26/97
2,100 $ 3 19/71
Kairos 10/06/2000 5,000 $ 3 13/33
Kairos 10/05/2000 1,000 $ 3 23/59
3,500 $ 3 17/40
2,500 $ 3 29/56
4,000 $ 3 26/57
3,000 $ 3 31/68
4,000 $ 3 39/80
3,000 $ 3 11/20
3,500 $ 3 30/49
4,000 $ 3 49/80
10,000 $ 3 46/75
3,500 $ 3 30/49
4,000 $ 3 25/43
3,500 $ 3 11/20
Kairos 10/04/2000 900 $ 3 9/23
Kairos 10/03/2000 4,500 $ 3 12/17
3,000 $ 3 63/82
4,500 $ 3 47/73
Kairos 10/02/2000 2,900 $ 3 19/39
3,500 $ 3 73/99
</TABLE>
Page 11 of 12 pages
<PAGE>
<TABLE>
<CAPTION>
Date of Number of Shares Purchase or Sale
Name of Purchase of Purchased or Price per
Shareholder Sale (Sold) Share
-------------------------- ------------------ ---------------------- -------------------
<S> <C> <C> <C>
Kairos 10/02/2000 100 $ 3 2/5
3,500 $ 3 37/94
3,500 $ 3 19/39
Kairos 09/21/2000 4,000 $ 4 13/33
2,000 $ 4 23/86
4,000 $ 4 1/3
5,000 $ 4 1/3
4,000 $ 4 18/67
2,100 $ 3 85/89
2,100 $ 4 1/57
3,000 $ 4 1/7
1,000 $ 4 17/84
2,000 $ 4 13/55
2,100 $ 4 13/55
Kairos 09/19/2000 1,900 $ 3 17/19
100 $ 3 11/14
3,900 $ 3 10/13
1,300 $ 3 65/66
3,800 $ 4 1/50
1,000 $ 3 43/54
2,000 $ 4 2/41
3,500 $ 4 1/54
10,000 $ 4 1/51
7,000 $ 3 17/19
4,000 $ 3 22/23
2,000 $ 4 1/57
8,000 $ 4 1/52
11,800 $ 4 1/52
15,000 $ 4 1/54
8,000 $ 4 1/52
15,000 $ 4 1/54
7,500 $ 4 1/52
12,000 $ 4 1/53
8,000 $ 4 1/52
7,500 $ 4 1/52
12,700 $ 4 1/53
</TABLE>
The shares of Common Stock were purchased by Kairos in the over-the-counter
market.
Page 12 of 12 pages
|
|